DK1250313T3 - Monohydrat af cis-lithium-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexancarboxylat - Google Patents

Monohydrat af cis-lithium-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexancarboxylat

Info

Publication number
DK1250313T3
DK1250313T3 DK01904886T DK01904886T DK1250313T3 DK 1250313 T3 DK1250313 T3 DK 1250313T3 DK 01904886 T DK01904886 T DK 01904886T DK 01904886 T DK01904886 T DK 01904886T DK 1250313 T3 DK1250313 T3 DK 1250313T3
Authority
DK
Denmark
Prior art keywords
cyclohexanecarboxylate
cyclopentyloxy
monohydrate
methoxyphenyl
cis
Prior art date
Application number
DK01904886T
Other languages
Danish (da)
English (en)
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1250313T3 publication Critical patent/DK1250313T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01904886T 2000-01-26 2001-01-18 Monohydrat af cis-lithium-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexancarboxylat DK1250313T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26
PCT/US2001/001487 WO2001055094A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Publications (1)

Publication Number Publication Date
DK1250313T3 true DK1250313T3 (da) 2007-02-12

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01904886T DK1250313T3 (da) 2000-01-26 2001-01-18 Monohydrat af cis-lithium-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexancarboxylat

Country Status (36)

Country Link
US (1) US6699903B2 (es)
EP (1) EP1250313B1 (es)
JP (1) JP2003520842A (es)
KR (1) KR20020073183A (es)
CN (1) CN1157371C (es)
AP (1) AP1432A (es)
AR (1) AR027273A1 (es)
AT (1) ATE344235T1 (es)
AU (1) AU3282201A (es)
BG (1) BG106959A (es)
BR (1) BR0107709A (es)
CA (1) CA2397758A1 (es)
CO (1) CO5300517A1 (es)
CY (1) CY1108515T1 (es)
CZ (1) CZ20022590A3 (es)
DE (1) DE60124221T2 (es)
DK (1) DK1250313T3 (es)
DZ (1) DZ3285A1 (es)
EA (1) EA200200791A1 (es)
EG (1) EG24065A (es)
ES (1) ES2273804T3 (es)
HK (1) HK1051030A1 (es)
HU (1) HUP0204150A3 (es)
IL (1) IL150400A0 (es)
MA (1) MA25652A1 (es)
MX (1) MXPA02007300A (es)
MY (1) MY122802A (es)
NO (1) NO20023378L (es)
NZ (1) NZ519799A (es)
OA (1) OA12159A (es)
PE (1) PE20011040A1 (es)
PL (1) PL356832A1 (es)
PT (1) PT1250313E (es)
SK (1) SK10942002A3 (es)
WO (1) WO2001055094A1 (es)
ZA (1) ZA200205925B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
BR0107709A (pt) 2002-11-19
MY122802A (en) 2006-05-31
CO5300517A1 (es) 2003-07-31
CZ20022590A3 (cs) 2003-01-15
CN1395556A (zh) 2003-02-05
CY1108515T1 (el) 2014-04-09
IL150400A0 (en) 2002-12-01
DZ3285A1 (fr) 2001-08-02
EP1250313A4 (en) 2005-09-21
PE20011040A1 (es) 2001-10-31
OA12159A (en) 2006-05-08
AR027273A1 (es) 2003-03-19
BG106959A (en) 2003-05-30
AU3282201A (en) 2001-08-07
AP2002002566A0 (en) 2002-06-30
HUP0204150A3 (en) 2003-05-28
WO2001055094A1 (en) 2001-08-02
SK10942002A3 (sk) 2002-11-06
EP1250313B1 (en) 2006-11-02
US6699903B2 (en) 2004-03-02
NO20023378D0 (no) 2002-07-12
PL356832A1 (en) 2004-07-12
EP1250313A1 (en) 2002-10-23
MXPA02007300A (es) 2002-11-29
AP1432A (en) 2005-06-20
CN1157371C (zh) 2004-07-14
NO20023378L (no) 2002-07-12
ZA200205925B (en) 2003-11-21
MA25652A1 (fr) 2002-12-31
NZ519799A (en) 2004-04-30
DE60124221D1 (de) 2006-12-14
EA200200791A1 (ru) 2002-12-26
JP2003520842A (ja) 2003-07-08
US20030032670A1 (en) 2003-02-13
HUP0204150A2 (hu) 2003-04-28
ATE344235T1 (de) 2006-11-15
KR20020073183A (ko) 2002-09-19
PT1250313E (pt) 2007-01-31
ES2273804T3 (es) 2007-05-16
DE60124221T2 (de) 2007-09-13
CA2397758A1 (en) 2001-08-02
HK1051030A1 (zh) 2003-07-18
EG24065A (en) 2008-05-08

Similar Documents

Publication Publication Date Title
CY2013048I2 (el) Παραλλαγη τροποποιημενου ιου vaccinia ankara
CY2004011I1 (el) Aσυμμετρη συνθεση της πρεγαβαλινης
DK1438306T3 (da) Derivater af UK-2A
ID30187A (id) Dongkrak jenis pantagraf
ID30465A (id) Mekanisme pengarah petransmisi daya selubung
DK1250313T3 (da) Monohydrat af cis-lithium-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexancarboxylat
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
SI1250313T1 (sl) Monohidrat cis-litij-ciano-4(3-(ciklopentiloksi)-4-metoksifenil) cikloheksankarboksilata
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
UA4410S (uk) Набір етикеток для презервативів
SE0103831D0 (sv) Use of a composition
IDP000026456A (id) Senyawa-senyawa siklopropanakarboksilat ester
UA3987S (uk) Комплект етикеток
UA4306S (uk) Комплект етикеток
UA4641S (uk) Набір етикеток
UA4194S (uk) Комплект етикеток
UA4783S (uk) Комплект етикеток
UA4538S (uk) Комплект етикеток
UA4187S (uk) Комплект етикеток
UA3988S (uk) Комплект етикеток
UA4559S (uk) Комплект етикеток
UA4058S (uk) Комплект етикеток
FR2807087B1 (fr) Batiment, notamment du type a couverture legere
UA5027S (uk) Комплект етикеток
UA6113S (uk) Комплект етикеток